Articles On Star Combo Pharma (ASX:S66)

Many ASX top dividend payers don’t offer fully franked dividends What’s the difference between franked and unfranked dividends? And which is better?    It’s that time of the year again when companies dole out dividends to loyal investors....

  Star Combo Pharma (ASX:S66) CEO Su Zhang presents at the Beijing Two Zones Investment Promotion Webinar (Australia Roadshow), May 2024.

  Su Zhang, CEO, Star Combo Pharma (ASX:S66) is a leading manufacturer and distributor of premium health and natural beauty products, with its high quality development and manufacturing facilities located in Sydney, Australia.

Star Combo Pharma (ASX:S66) has attained a notable achievement with the issuance of a manufacturing license by the Therapeutic Goods Administration (TGA) for the production of pastille products tailored for the Gummy market. This regulatory...

28 May 2024 - Star Combo Pharma (ASX:S66) has attained a notable achievement with the issuance of a manufacturing license by the Therapeutic Goods Administration (TGA) for the prod…

Morgans says companies on the ASX are propelling our appetite product for health and wellness products Bioxyne says Covid has shown our susceptibility to disease, but also how resilient and strong we are in fighting it Anagenics says it’s...

ASX closes out the day lower by about 0.74% Online matchmakers Love Group goes on a bodice-busting 39% jag Woman tries to stop eviction with a swarm of bees. No, really…   Aussie markets are set to meander to a close around 0.74% down for...

Highlights The consumer sector has underperformed the broader market in 2022. However, small cap consumer stocks such as S66, ATP and DLC are off to a good start. Investing in small caps should be done only after proper due diligence....

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

The ASX rose 0.48% today to reach its highest point in the week. While energy lost 2% most other sectors were in the green with tech and financials gaining over 1%. Today’s gains came despite the Federal Reserve unveiling a tapering of stim...

The ASX 200 Health Index (XHJ) is up by 0.40% at the time of writing, compared to the broader index which is higher by 0.30%. Neurology specialist, Invex Therapeutics (ASX:IXC), soared 13% after announcing that it’s about to launch a Phase...

ShareCafeHidden Gems Webinar Recap – S66, MEY, AU1, NC6   Catch up on the full webinar with presentations from Star Combo Pharma (ASX: S66), Marenica Energy (ASX: MEY), The Agency Group (ASX: AU1) and Nanollose Limited (ASX: NC6). Hidden G...

ShareCafeStar Combo Pharma (ASX: S66) – Hidden Gems Webinar Presentation   Presenter – Su Zhang – Founder & MD – Star Combo Pharma is a leading manufacturer and distributor of premium health and natural beauty products, with its high q...

Star Combo Pharma (ASX:S66) has announced the expansion of its manufacturing capabilities at its wholly-owned TGA-licensed nutraceutical manufacturing site in Sydney.

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

A quick wrap of the key winners and losers on Thursday, April 30. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. WINNERS CODE COMPANY PR...

It’s a bleak morning for ASX stocks in the tourism and China-focused sectors. A contravirus began in the Chinese city of Wuhan and while the city is now in lockdown mode, about 5 million people left beforehand due to the Lunar New Year holi...

Star Combo Pharma Limited (ASX: S66) announced that it has entered into an agreement to acquire 51% of Australian Inature Organic Care Pty Limited (Inature) under which it will be able to access new consumer health products in the pre-natal...

The consumer staples are an essential need of every individual. The sector is primarily formed of companies related to food, beverage and other household items. Additionally, the S&P ASX 200 consumer staples index witnessed a rise of 0....

The company has a substantial pipeline of future product launches to drive growth in the 2020 financial year.

Vitamins and supplements manufacturer Star Combo Pharma (ASX: S66) is raising capital to fund the acquisition of Australian natural health, food and beauty product company Bio-E Australia Pty Ltd. The Sydney-based company emerged from a tra...

Sydney-based nutrition firm Star Combo Pharma is trying to pivot to a branded business with the $60 million acquisition of Melbourne health company Bio-E.

Leading distributor and manufacturer of branded premium health and natural beauty products, Star Combo Pharma Ltd (ASX:S66) has made a transformational acquisition which will not only contribute underlying earnings of $14.7 million in fisca...

Listed health foods and vitamins company Star Combo Pharma is in front of fund managers, seeking support for a potentially company-changing M&A deal and equity raising.